Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,227 public trials 1,016 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors

NCT04731467

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +48 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • University of Colorado Aurora, Colorado, United States
  • Yale University New Haven, Connecticut, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View all 18 locations
View Trial Details
Completed

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

NCT03997968

Conditions
Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +68 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
View all 16 locations
View Trial Details
Completed

Durvalumab Long-Term Safety and Efficacy Study

NCT04078152

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Fullerton, California, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Augusta, Georgia, United States
  • Research Site Baltimore, Maryland, United States
View all 116 locations
View Trial Details
Completed

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

NCT03150810

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +39 more
Locations
  • Start Midwest Grand Rapids, Michigan, United States
  • Washington University in St Louis St Louis, Missouri, United States
  • Mount Sinai Prime New York, United States
  • Montefiore Medical Park At Eastchester Einstein Campus The Bronx, New York, United States
View all 22 locations
View Trial Details
Completed

Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)

NCT01463423

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Stanford University Cancer Institute Stanford, California, United States
  • Swedish Cancer Institute Seattle, Washington, United States
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
  • Hokkaido University Hospital Sapporo, Hokkaido, Japan
View Trial Details
Completed

Dose Individualization of Pemetrexed - IMPROVE-I

NCT03656549

Conditions
Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • Jeroen Bosch Hospital 's-Hertogenbosch, Netherlands
  • Antoni van Leeuwenhoek Amsterdam, Netherlands
  • Catharina hospital Eindhoven, Netherlands
  • Maastricht University Medical centre Maastricht, Netherlands
View Trial Details
Completed

Clinical Outcomes of Patients With Resectable Non-Small Cell Lung Cancer Receiving Neoadjuvant Nivolumab Plus Chemotherapy in France

NCT06735781

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Centre François Baclesse Caen, France
  • Centre Léon Bérard Lyon, France
  • Hospices Civils de Lyon Lyon, France
  • Hôpital Robert Schuman Metz, France
View Trial Details

Related conditions